Follow us on twitter: @csjmagazine
IBD research reaches new milestone
A platform to help find new treatments for Crohn’s Disease and Ulcerative Colitis has smashed researchers’ recruitment target, two years ahead of schedule.
The National Institute for
Health Research (NIHR) Inflammatory Bowel Disease (IBD) BioResource gives people who have been diagnosed with Crohn’s Disease and Ulcerative Colitis a chance to be a part of a national programme to support research into these diseases.
Dr Miles Parkes
The aim is to provide investigators researching IBD immediate access to people and speed up their research to create new treatments. Founded in 2016 by the UK IBD Genetics
Consortium and the NIHR BioResource for Translational Research, the NIHR IBD BioResource began to create a national resource of well characterised individuals who are affected by the disease, with hospitals helping to recruit patients.
The aim was to have 25,000 patients signed up to the NIHR IBD BioResource at sites across the country within the first five years. In 2019 the NIHR IBD BioResource has exceeded expectations by meeting the goal two years early – with numbers still rising. To date, the team has successfully signed up more than 25,000 people and has over 90 hospitals actively recruiting patients. Research is also underway, with more than 10 studies using the NIHR IBD BioResource. Dr Miles Parkes, a consultant
gastroenterologist at Cambridge University Hospitals and lead for NIHR IBD BioResource, said: “Getting to the 25,000 initial recruitment mark is a fantastic tour de force. The NIHR IBD BioResource is a nationwide effort, recruiting people who have Crohn’s Disease or Ulcerative Colitis specifically so that they can help researchers to better understand the causes of
IBD and develop better treatments.” In the UK, at least 300,000 people are affected by Crohn’s disease or Ulcerative Colitis, with growing evidence that the number could be almost double that. Despite major advances in characterising the genetic and some of the environmental factors that predispose, much work remains to be done to fully understand IBD and develop better treatments. Having this large cohort of people will give researchers a
wealth of knowledge from the recent genetics advances and access to a range of people who have different variations of the disease. Dr Parkes explained: “People who sign up to the NIHR IBD BioResource provide a small blood sample and complete a short health and lifestyle questionnaire. They will be contacted regarding future research projects for which they meet inclusion criteria and given further information. “They then decide study-by-study if they would like to participate or not. The studies could range from completing an online survey, to providing a fresh blood sample or even participating in a trial of a new treatment. Our ongoing large-scale recruitment of patients will allow us to fulfill our mission - to facilitate outstanding IBD research in the UK.” The NIHR IBD BioResource now hopes to increase the recruitment target to 50,000 participants over the next five years. This will increase the number of recruitment sites and researchers using this resource for their work in Crohn’s Disease, Ulcerative Colitis and non- IBD studies. For more information on the NIHR IBD
BioResource a website is available and explains how people with Crohn’s Disease or Ulcerative Colitis can sign up, and how clinicians and investigators can get involved and access the IBD BioResource.
www.ibdbioresource.nihr.ac.uk
‘Clean hands
for all’campaign Skin and surface hygiene specialist, GOJO Industries-Europe is advocating making hand hygiene second nature to everyone on Global Handwashing Day (Tuesday 15 October 2019).
The annual worldwide advocacy day is dedicated to increasing awareness and understanding about the importance of handwashing. The campaign ultimately helps to influence behaviour change and encourage healthy hand hygiene. Inequalities in handwashing facilities can put individuals at higher risk to diseases that impact their health, education, and economic outcomes. Chris Wakefield, vice president, European Marketing & Product Development, GOJO Industries-Europe, said: “We are a strong advocate of the ‘total solution’ approach to making hand hygiene second nature to everyone. By educating about the importance of hand hygiene, and teaching best practice techniques, we can help reduce diseases and save lives. ‘Clean Hands for All’ will help achieve ‘Health for All’.”
QIST to focus
on Anaemia November’s Quality Improvement for Surgical Teams (QIST) event will focus on anaemia. The event, “Welcome to round 2 of the
QIST: Anaemia Collaborative Project,” takes place at Clayton Hotel in Birmingham on Tuesday 12 November 2019 from 10am to 4pm. It is only open to NHS Trust staff involved in the QIST.
NEWS
The Brigh
htest. The Best. The SSL-9500.
brightest LED surgical headlight on the market An inc
comparable 1190k Lu ux of light
info@uniplexuk.com |
www.uniplexuk.com | 0114 241 3410 OCTOBER 2019
WWW.CLINICALSERVICESJOURNAL.COM I 9
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
